FDA Approves Gene Therapies for Sickle Cell Disease

Two cell-based gene therapies will address the debilitating hereditary blood disorder. The U.S. Food and Drug Administration (FDA) has granted approval of two groundbreaking cell-based gene therapies, Casgevy…

Read More

Roundtable on Sickle Cell Disease Held by First Lady

100k Americans affected, including approximately 1 in 365 African-Americans. First Lady Melania Trump hosted a roundtable discussion earlier this week at the White House regarding Sickle Cell Disease…

Read More

Back to top